Published on 10 Nov 2021 on Zacks via Yahoo Finance
Scynexis (SCYX) Reports Q3 Loss, Tops Revenue Estimates
Scynexis (SCYX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 92.41%. A quarter ago, it was expected that this pharmaceutical company would post a loss of $0.58 per share when it actually produced a loss of $0.22, delivering a surprise of 62.07%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.